-
Loading metrics
Open Access
Peer-reviewed
Research Article
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen
-
Federica Frezzato,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Cristina Gattazzo,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Veronica Martini,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Valentina Trimarco,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Antonella Teramo,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Samuela Carraro,
Affiliation Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Anna Cabrelle,
Affiliation Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy
⨯ -
Elisa Ave,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Monica Facco,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Renato Zambello,
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Elena Tibaldi,
Affiliation Department of Molecular Medicine, University of Padua, Padua, Italy
⨯ -
Anna Maria Brunati,
Affiliation Department of Molecular Medicine, University of Padua, Padua, Italy
⨯ -
Gianpietro Semenzato ,
* E-mail: g.semenzato@unipd.it
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯ -
Livio Trentin
Affiliations Venetian Institute of Molecular Medicine (VIMM), Centro di Eccellenza per la Ricerca Biomedica, Padua, Italy, Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy
⨯
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen
- Federica Frezzato,
- Cristina Gattazzo,
- Veronica Martini,
- Valentina Trimarco,
- Antonella Teramo,
- Samuela Carraro,
- Anna Cabrelle,
- Elisa Ave,
- Monica Facco,
- Renato Zambello
- Published: June 29, 2012
- https://doi.org/10.1371/journal.pone.0039902